$1.14
-0.005-0.44%
Last update: Oct 23, 5:58 PM
Acurx Pharmaceuticals Inc
ACXPNASDAQ
Acurx Pharmaceuticals (ACXP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.43 | $-0.63 | $-1.00 | $-1.54 |
| Actual | $-0.53 | $-0.62 | $-0.73 | $-1.23 |
| Surprise | -23.3% | +1.59% | +27.0% | +20.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.43 | $-0.45 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.53 | $-0.43 | -23.3 % |
| Q1 | May 11, 2026 | $-0.62 | $-0.63 | 1.59 % |
| Q4 | Mar 13, 2026 | $-0.73 | $-1.00 | 27.0 % |
| Q3 | Nov 12, 2025 | $-1.23 | $-1.54 | 20.1 % |
